Volume 11, supplement issue 1, December 2011
5th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
- Issue editors
115 articles in this issue
-
-
-
-
-
-
-
-
Redox regulation of responses to hypoxia and NO-cGMP signaling in pulmonary vascular pathophysiology
Authors (first, second and last of 6)
-
Nitric oxide-independent stimulation of soluble guanylate cyclase attenuates pulmonary fibrosis
Authors (first, second and last of 12)
-
-
Structural insights into sGC activation by different activators
Authors (first, second and last of 9)
-
-
-
The crystal structures of PKG Iβ (92-227) with cGMP and cAMP reveal the molecular details of cyclic-nucleotide binding
Authors (first, second and last of 11)
-
Characterization of mice with a deletion of protein kinase G type I in cardiomyocytes and the effect on cardioprotection through either postconditioning or mitochondria-targeted S-nitrosothiol
Authors (first, second and last of 5)
-
Effects of long-term proBNP cardiac gene delivery in experimental hypertensive heart disease
Authors (first, second and last of 6)
-
-
-
-
Molecular targets for PDE inhibitor-mediated improvement of cardiac dysfunction in the mdx mouse?
Authors (first, second and last of 9)
-
-
-
-
Src activation by cGMP/PKG II in osteoblasts: characterization of a mechano-sensitive signalling complex
Authors (first, second and last of 9)
-
cGMP/cGKI signaling in peripheral vascular smooth muscle does not involve TrpC3 or TrpC6 channels
Authors (first, second and last of 4)
-
-
-
-
cGMP modulates stem cells differentiation to neurons in brain in vivo pathological implications
Authors (first, second and last of 9)
-
-
-
-
NO resistance in angiotensin II–induced hypertension is associated with S-nitrosation of soluble guanylyl cyclase
Authors (first, second and last of 9)
-
-
-
-
Treatment with CBA-NP a novel chimeric natriuretic peptide attenuates cardiorenal fibrosis and improves diastolic dysfunction in diabetic rat model
Authors (first, second and last of 4)
-
Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
Authors (first, second and last of 6)
-
-
Comparison of different vasodilators, endothelin antagonist, PDE5 inhibitior and sGC stimulators, in an animal model of secondary pulmonary hypertension: effects on “desaturation”
Authors (first, second and last of 4)
-
-
Evidence for two catalytic centers and Mn2+ as physiological cofactor of soluble guanylyl cyclase
Authors (first, second and last of 4)
-
Targeting of soluble guanylyl cyclase limits infarct size in a model of acute myocardial infarction
Authors
-
Protein kinase G I alpha activates an anti-remodeling signaling pathway in the heart via an interaction with the MAPKKK mixed lineage kinase 3
Authors (first, second and last of 7)
-
-
Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines
Authors (first, second and last of 4)
-
Quantitation of cyclic nucleotides in mammalian cells and in human urine by high-performance liquid chromatography/mass spectrometry
Authors (first, second and last of 8)
-
sGCα1-deficient mice: a novel murine model of spontaneous primary open angle glaucoma
Authors (first, second and last of 15)
-
Genetic mapping of a modifier locus affecting hypertension in soluble guanylate cyclase α1 deficient mice
Authors (first, second and last of 9)
-
